SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
45 hedge funds and large institutions have $205M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 1 closing their positions.
Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
15
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$2.86M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.1M |
3 |
OM
3
Opaleye Management
Boston,
Massachusetts
|
$400K |
4 |
4
State Street
Boston,
Massachusetts
|
$976K |
5 |
5
Wells Fargo
San Francisco,
California
|
$225K |
Top Sellers
1 |
DM
1
Deerfield Management
New York
|
$25.7M |
2 |
2
Morgan Stanley
New York
|
$173K |
3 |
3
Goldman Sachs
New York
|
$0 |
4 |
WMSA
4
Weiss Multi-Strategy Advisers
New York
|
$637K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$1.92M |